Follicular dendritic-like cells derived from human monocytes by Heinemann, Dagmar EH & Peters, J Hinrich
BioMed  Central
Page 1 of 13
(page number not for citation purposes)
BMC Immunology
Open Access Research article
Follicular dendritic-like cells derived from human monocytes
Dagmar EH Heinemann1 and J Hinrich Peters*2
Address: 1Max-Planck-Institut für Biophysikalische Chemie, D-37077 Goettingen, Germany and 2Abteilung für Immunologie, D-37075 Göttingen, 
Germany
Email: Dagmar EH Heinemann - dheinem@gwdg.de; J Hinrich Peters* - hpeters@gwdg.de
* Corresponding author    
Abstract
Background: Follicular dendritic cells (FDCs) play a central role in controlling B-cell response
maturation, isotype switching and the maintenance of B-cell memory. These functions are based on
prolonged preservation of antigen and its presentation in its native form by FDCs. However, when
entrapping entire pathogens, FDCs can turn into dangerous long-term reservoirs that may
preserve viruses or prions in highly infectious form.
Despite various efforts, the ontogeny of FDCs has remained elusive. They have been proposed to
derive either from bone marrow stromal cells, myeloid cells or local mesenchymal precursors. Still,
differentiating FDCs from their precursors in vitro may allow addressing many unsolved issues
associated with the (patho-) biology of these important antigen-presenting cells. The aim of our
study was to demonstrate that FDC-like cells can be deduced from monocytes, and to develop a
protocol in order to quantitatively generate them in vitro.
Results: Employing highly purified human monocytes as a starter population, low concentrations
of Il-4 (25 U/ml) and GM-CSF (3 U/ml) in combination with Dexamethasone (Dex) (0.5 µM) in
serum-free medium trigger the differentiation into FDC-like cells. After transient de-novo
membrane expression of alkaline phosphatase (AP), such cells highly up-regulate surface expression
of complement receptor I (CD35). Co-expression of CD68 confirms the monocytic origin of both,
APpos and CD35pos cells. The common leukocyte antigen CD45 is strongly down-regulated.
Successive stimulation with TNF-α up-regulates adhesion molecules ICAM-1 (CD54) and VCAM
(CD106). Importantly, both, APpos as well as APneg FDC-like cells, heterotypically cluster with and
emperipolese B cells and exhibit the FDC characteristic ability to entrap functionally preserved
antigen for prolonged times. Identical characteristics are found in monocytes which were highly
expanded in vitro by higher doses of GM-CSF (25 U/ml) in the absence of Dex and Il-4 before
employing the above differentiation cocktail.
Conclusion: In this work we provide evidence that FDC-like cells can be derived from monocytes
in vitro. Monocyte-derived FDC-like cells quantitatively produced offer a broad utility covering basic
research as well as clinical application.
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Background
Until today, the ontogeny of follicular dendritic cells
(FDCs) has remained unresolved [1,2]. Even transplanta-
tion experiments have led to contradictory results [3-11].
Researchers contemplating a bone marrow origin have
suggested that these professional antigen-presenting cells
derive either from the lymphoid [5] or the myeloid line-
ages [10]; from monocytes in particular [12,13]; or even
from stromal cells of the bone marrow [6,11,14,15]. Alter-
natively, FDCs have been claimed to originate within lym-
phoid organs from local mesenchymal precursors
[6,7,11,14,16-18]. So far, however, no protocol is availa-
ble to generate FDCs in vitro from their putative progeni-
tors [2].
The monocyte is increasingly acknowledged as the corner-
stone of a plastic differentiation system. Accordingly, the
findings of a monocytic origin of both macrophages [19]
and dendritic cells (DCs) [20]; (for review see [21]) have
subsequently been complemented by evidence proving
that microglia [22] and osteoclasts [23] can be derived
from this cell type as well. More recent results have
revealed that even osteoblasts [24], neural cells, hepato-
cytes [25] and endothelial cells [26] can be generated
from certain monocyte subsets. Therefore, its remarkable
developmental capacity strongly indicates that the mono-
cyte actually represents a somatic stem cell.
Our previous findings demonstrated that the bone/liver/
kidney isozyme of Alkaline Phosphatase (AP) is likewise
expressed in cells obtained from ex vivo-explanted foreign-
body granuloma as well as in monocyte-derived in-vitro
granuloma. Co-expression of CD68 assigned such APpos
cells to the myeloid lineage. Intriguingly, cultured osteob-
lasts were found to be phagocytic and co-expressed AP
and CD68. Taken together, these results strongly implied
osteoblasts and macrophages to derive from a common
source [27,28]. AP of the bone/liver/kidney isozyme is
also expressed by osteoblasts, activated endothelial cells,
stromal reticulum cells [29]) as well as by FDCs [30]. Con-
sequently, we hypothesized that AP expression may con-
stitute a link between monocytes and mesenchymal cells
[27]. Indeed, when attempting to identify signals provok-
ing AP expression in monocytes, we found it transiently
up-regulated in GM-CSF-induced proliferating monocyte
cultures. AP expression was further enhanced and pro-
longed by IL-4. In the absence of IL-4, AP was down-regu-
lated, while typical osteoclast markers such as tartrate-
resistant acid phosphatase and vitronectin receptor, were
expressed [27].
Our present study aimed at determining whether FDCs
can be derived from the monocytic lineage. As a result, we
present evidence that under defined serum-free condi-
tions highly purified human monocytes differentiate into
functionally competent FDC-like cells. Low concentra-
tions of Il-4 and GM-CSF in combination with Dexameth-
asone (Dex) were used to induce AP expression as a
striking feature of these cultures accompanied by some of
the most important features of FDCs, expression of CD35
[31,32], B cell rosetting and emperipolesis [33], as well as
antigen trapping and retaining it for prolonged time [34].
Results
Generation and phenotyping of monocyte-derived primary 
FDC-like cells
Highly enriched human monocytes highly depleted of
lymphocytes and cultured for 12 or 15 days in the pres-
ence of IL-4 (25 U/ml), GM-CSF (3 U/ml) and Dex (0,5
µM), tightly adhered to the substratum, exhibited multi-
ple shapes as well as numerous projections and thrived
closely adjacent to one another. Typically, these cell vari-
ants strongly expressed AP (Fig. 1), with a peak on day 12.
These cells were referred to as primary FDC-like cells. For
a maximal expression of AP the three inducers had to be
present to act synergistically, whereas GM-CSF plus IL-4 in
the absence of Dex induced expression of AP to a lesser
extent only (Fig. 2a–d). IL-4 could be replaced by IL-13
(100 U/ml) (not demonstrated).
By triple-staining we found APpos and APneg cells express-
ing membrane-bound CD35 (complement receptor I)
(Fig. 3a). Both, APpos as well as CD35pos cells, could fur-
ther be co-stained for the monocyte/macrophage marker
CD68, thus revealing the myeloid origin of the cells (Fig.
3a). For control, AP expression was virtually absent, and
CD35 was only occasionally seen in parallel cultures
where monocytes had been induced to differentiate into
macrophages (Fig. 3b).
The common leukocyte marker CD45 was strongly down-
regulated in FDC-like cells, obviously correlating with AP
expression (Fig. 4a) as compared with constitutively
CD45pos macrophages (Fig. 4b).
B-cell rosetting and emperipolesis
When cultured for 14 days or longer, spontaneous homo-
typic clustering, B cell rosetting and emperipolesis, as well
as antigen retaining in its native form (see below) were
verifiable as characteristic functional features of FDCs. For
these experiments, initially autologous B cells (not
shown) and thereafter the Raji B-cell line was employed
(cf. Fig. 5a, and 5b for B-cell rosetting and emperipolesis
by FDC-like cells).
Antigen trapping and retention
Antigen retention for a longer period of time may be
regarded as the most defining and distinctive function of
FDCs. In order to investigate whether cultured monocyte
derivatives express this property, we employedBMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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horseradish peroxidase (HRPO) as a model antigen which
offers the advantage to be easily detectable by a standard
HRPO substrate reaction. The enzyme was offered in the
form of immune complexes of human Ig/HRPO-anti-
human IgG.
Complexes were likewise trapped by monocyte-derived
FDC-like cells and macrophages. In FDC-like cells HRPO
remained fully enzymatically active up to 16-days tested
(Fig. 6a, c). In contrast, control macrophages had almost
completely degraded the enzyme at 4 and 16 days, respec-
tively (Fig. 6b, d), already observable after 4 h (not
shown). Immune-complex loaded cells strongly co-
expressed CD35 as a typical FDC marker (Fig. 6c),
whereas control macrophages only marginally expressed
CD35. Only minimal numbers of cells revealed HRPO
activity (Fig. 6d).
Secondary stimulation
Based on these findings, an even more mature FDC phe-
notype was differentiable from the APpos phenotype under
secondary stimulation. When day12 APpos FDC-like cells
were pulsed for a further 3 to 5 days with 10 ng/ml TNF-
α, they were induced for increased expression of ICAM-1
(CD54) (Fig. 7a) and VCAM (CD106) was slightly up-reg-
ulated (Fig. 7c; see also Table 1). In control macrophage
cultures these markers were seen only occasionally (Fig.
7b,d). Both adhesion molecules as well as CD35 are hall-
marks of functionally competent FDCs in vivo [15,35].
Supplementing the cultures with TNF-β (LT-α) [36,37]
AP expression in FDC-like cells Figure 1
AP expression in FDC-like cells. After 15 days of culture the presence of Il-4 (25 U/ml), GM-CSF (3 U/ml) and Dex (0, 5 
µM), monocyte-derived cells were fixed and stained for AP (blue).BMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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did not reveal similar effects and IFN-γ up-regulated CD54
only, but down-regulated CD35 (not shown). Functional
markers such as B-cell rosetting and antigen retention
were not further up-regulated by secondary stimulation
(not shown).
Monocyte proliferation
Throughout the entire period of culture, the differentiat-
ing monocyte derivatives were tested in serial two day-
intervals for 5-bromodeoxyuridine (BrdU) incorporation.
The maximum of 1% positive cells was measured within
days 6 to 10 (not shown). This result clearly excluded the
outgrowth of a certain cell subset(s) while underscoring a
direct derivation of APpos cells from monocytes.
As an alternative source, we used monocytes derived from
8- to 10-day cultures in which – as a first step – prolifera-
tion had been induced with GM-CSF at 25 U/ml. Cells
transferred from this condition, and immediately intro-
duced to FDC-inducing conditions specified above,
ceased to proliferate and acquired the complete pheno-
type of primary FDC-like cells (not shown).
Synergistic action of AP-inducing factors Figure 2
Synergistic action of AP-inducing factors. Monocytes were cultured in the presence of a, 25 U/ml Il-4 and 3 U/ml GM-
CSF; b, 0, 5 µM Dex; c, 3 U/ml GM-CSF; d, 25 U/ml Il-4, 3 U/ml GM-CSF and 0, 5 µM Dex (full mix). On day 15, the cultures 
were fixed and stained for expression of AP.
a b
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Discussion
In the present study, we demonstrate for the first time the
in-vitro generation of FDC-like cells from monocytes as
their putative precursors. Human monocytes were pre-
pared by selective adherence combined with reverse sedi-
mentation as a novel procedure in order to eliminate
undesired non-adherent cell populations. This protocol
allowed for a virtual enrichment of monocytes while
avoiding any interference with antibodies posing the
potential hazard to evoke adverse cellular trigger events.
Our data clearly demonstrate that peripheral blood
monocytes can be induced to differentiatiate into FDC-
like cells. Similar to the earlier conundrum on the ontog-
eny of T cell-tropic dendritic cells (DCs) [21], the search
for the origin of FDCs has always been complicated by
their unstable marker profile, showing that FDCs isolated
from lymphoid organs readily lose typical antigens such
as DRC-1, CD21, CD23, and KiM4 in culture [35,38,39].
For practical reasons, we therefore decided to take advan-
tage of an AP isoenzyme that has been described to be
expressed by FDCs [30], but not by monocytes, macro-
phages or monocyte-derived DCs (cf. Tab. 1). Actually,
our earlier experiments had revealed that this anchor
marker is inducible in monocytes under defined condi-
tions, suggesting AP expression as indicative for the devel-
opmental plasticity of these cells [27]. As a logical step,
when attempting to generate FDCs in vitro, we first con-
verted monocytes into APpos cells, here referred to as pri-
mary FDC-like cells.
APpos cells express the FDC-marker CD35 and the myeloid marker CD68 Figure 3
APpos cells express the FDC-marker CD35 and the myeloid marker CD68. Monocytes were cultured under condi-
tions described in Fig. 1 for differentiating into FDC-like cells (a) or for macrophages (b) and triple-stained for AP, CD 35 and 
CD68. a, FDC-like cells co-expressing CD68 (red; filled arrow), AP (blue; open arrow), and CD35 (brown; arrowhead) at dif-
ferent degrees; b, control cells cultured in parallel in the presence of macrophage differentiation conditions stained for AP 
(negative), CD35 (negative), CD68 (positive, red).
abBMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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Typically, the common leukocyte antigen CD45 was
strongly down-regulated in APpos cells as well as in cells
with similar morphology suggesting a transdifferentiation
into non-leukocytic cells. Absence of CD45 has been
described for FDCs by Schriever et al. [40]. The co-expres-
sion of CD68, however, indicates the monocytic origin of
the APpos cells.
Labelling of CD35 (complement receptor I) is routinely
used in histology to discriminate FDCs from other types
of dendritic cells as well as from histiocytes [31,32]. In our
work CD35 was stably expressed in monocyte-derived
FDC-like cells. Again, we found the monocyte/macro-
phage marker CD68 in CD35pos cells which was also
obvious in CD35/AP co-expressing cells. Control macro-
phages were stained only marginally or negatively for
CD35.
When establishing conditions for the generation of APpos
cells, sera were found to give variable results. Therefore,
we developed a completely serum-free differentiation pro-
tocol. Low concentrations of IL-4 and GM-CSF plus Dex
were found to act as basic inducers. Within 12 to 15 days
of culture, these conditions elicited a cell showing mark-
ers and functions of FDCs. Conversely, this combination
of factors prevented the differentiation of macrophages or
T-cell tropic dendritic cells from monocytes.
IL-4 at concentrations one order of magnitude lower than
those established for the differentiation of T-cell tropic
DCs had previously been shown to generate large flat-
tened and adherent cells with fine dendritic protrusions.
Such cells had shown to express both, AP as well as the
myeloid marker CD68 [27]. Our forthcoming experi-
ments revealed that IL-4 can successfully be replaced by
IL-13, which will be a subject of further research.
Down-regulation of CD45 in FDC-like cells Figure 4
Down-regulation of CD45 in FDC-like cells. Co-staining for AP and CD45 in FDC-like cells or macrophages. a, CD45 
(brown) is down-regulated in FDC-like AP-positive (blue) cells compared with b, macrophages as controls where CD45 is fully 
expressed, and AP is negative.
a bBMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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Importantly, corticosteroids such as Dex synergistically
enhanced AP expression. Dex, previously employed to
induce osteoblasts from bone-marrow derived mesenchy-
mal stem cells [41], has been shown to inhibit macro-
phage and DC differentiation [42]. When differentiating
FDCs from monocytes, we now have found that IL-4 and
Dex synergize in inducing the APpos phenotype.
GM-CSF which was applied routinely at low concentra-
tions appeared merely to serve as a survival factor in addi-
tion to its contribution to differentiation. Its actual
requirement was largely donor-dependent, indicating that
developmental properties of starter monocytes may vary
according to the donor's immunological status. Moreover,
we have experienced that occasionally exogenous GM-CSF
can even be omitted without affecting the differentiation
towards APpos cells, which might be explained by an auto-
crine production of GM-CSF by monocytes in culture
[43].
After 12–15 days of culture, the majority of monocyte-
derived cells displayed the APpos phenotype, while not
proliferating throughout this period of time. This high
percentage of APpos cells therefore reflects quantitative
monocytic differentiation and clearly argues against the
possibility that FDC-like cells might have expanded from
a small contaminating cell population.
Alternatively, we used monocytes in which – as a first step
– proliferation had been induced by adding GM-CSF at
higher concentrations. Cells transferred from this condi-
tion and introduced to FDC-inducing conditions acquired
the APpos phenotype as well. As a consequence, combining
sequential proliferation and differentiation might emerge
as the method of choice when considering large-scale pro-
duction of FDC-like cells from monocytes, for example
when faced with the need to avail such cells for therapeu-
tic application.
Membrane expression of ICAM-I and VCAM on FDCs has
been described as a prerequisite for the interaction of
FDCs and B cells within lymphoid tissues. We found a
strong up-regulation of ICAM-I after secondary stimula-
tion with TNF-α. However, we already obtained function-
ally competent FDC-like cells capable of B-cell rosetting
and antigen retention which strongly expressed CD35
under the TNF-α-free basic condition.
Development of functional germinal centres as well as the
maintenance of FDC function has been claimed to
Heterotypic B-cell rosetting and emperipolesis Figure 5
Heterotypic B-cell rosetting and emperipolesis. Primary FDC-like cells at day 14 were co-cultured with B-cells (Raji) at 
a ratio of 1:1 for 4 hours, fixed and double-stained for AP and CD22. a, APpos FDC-like cells (blue) with filamentous dendrites 
capturing CD22+ Raji cells (brown); b, survey of rosettes and various stages of emperipolesis.
a bBMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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Antigen trapping and long-term retention Figure 6
Antigen trapping and long-term retention. FDC-like cells (a, c) or macrophages (b, d), were pulsed for 30 min with 
HRPO/human IgG complexes. a, b, Cells were fixed after 4 days and double stained by a standard HRPO substrate reaction 
(brown) and for CD35 (red). a, In FDC-like cells antigen was present in its enzymatic active form, and CD35 was expressed. b, 
In macrophages only traces of antigen was detectable and CD35 is weakly positive. c, d, Cells were cultured for 16 days. In 
FDC-like cells (c) enzyme activity is still detectable, whereas in macrophages enzyme activity is absent.
ab
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strongly depend on the engagement of TNF family
members (TNF-α and LT-α/β) [36,37]. In-vitro generation
of FDC-like cells, as described herein, appears to be widely
independent of LT-α/β, whereas TNF-α may cause a fur-
ther maturation of the FDC phenotype. The expression of
HLA-DR which is controversial, but positively found by
some authors [35,39], was up-regulated by TNF-α as well
(Table 1).
Other factors were, however, inhibitory. Lymphocytes had
to be eliminated as far as possible – which, especially
when activated, inhibited the observed transdifferentia-
tion. Specifically, IFN-γ may be the main factor: when
added to monocytes as early as at the onset of culture, it
strictly inhibited APpos  phenotype, as we have shown
before [27]. When added in a secondary step after 12 days
of culture, IFN-γ up-regulated expression of CD54, but
down-regulated CD35.
Of note, emperipolesis specifying the prolonged engulf-
ment of B cells is a unique FDC property which, within
germinal centres, is implicated in the protection of tran-
siently internalised B cells from apoptosis [33]. It is envi-
sioned that this property may be useful for preserving
immunogenic or tolerogenic B cells triggered in vitro for
their subsequent clinical application.
Up-regulation of adhesion molecules after secondary stimulation Figure 7
Up-regulation of adhesion molecules after secondary stimulation. TNF-α added to FDC-like cells on day 13 for fur-
ther three days expressed ICAM-1 (CD54) (a) and VCAM (CD106) (c) on day 16; b, d, macrophages as controls.
ab
cdBMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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Identifying these newly differentiated cells as FDC-like
cells culminates in the demonstration of storing antigen
for long periods of time in its native form. This ability has
been described as a unique feature of FDCs [34] but, to
our knowledge, neither for other types of dendritic cells
nor for macrophages. Specifically, in FDC-like cells the
antigen, provided as HRPO-IgG complexes, was retained
in an enzymatic active form up to 16 days tested. Enzyme
activity was localized perinuclearly. In contrast, macro-
phages eliminated the material within a few hours. Fur-
ther studies will reveal the precise kinetics of uptake, sub-
cellular distribution, storage and possible re-expression
on the FDC surface by ultrastructural investigations.
Monocyte-derived FDC-like cells can now be generated in
vitro. Obviously, one pertinent employment of this system
is to spur on the further elucidation of the underpinnings
of immunological B-cell memory. Furthermore, cultures
of FDCs may greatly facilitate research on the mechanisms
underlying the capture and functional preservation of
antigen. Next, because antigen retention is known to be
exploited by pathogenic entities such as the human
immunodeficiency virus-1 (HIV-1) [44] as well as prions
[45], close investigation of these processes in vitro pro-
vides hope for important progress in these areas. For
example, Smith et al. nicely demonstrated on isolated
human FDCs, and in murine models alike, that FDC-
entrapped HIV-1 remains highly infective for prolonged
times, which appears to be due to protection of this virus
from degradation [46]. Last but not least, this novel pro-
tocol might even foreshadow later clinical applications of
autologous FDCs or FDC-preserved B cells akin to the
clinical studies currently conducted with T cell-tropic
DCs. In conclusion, the present findings may open up
new horizons for unraveling the secrets of antigen and
pathogen storage by FDCs, with self-evident immunolog-
ical and clinical implications.
Other groups have shown other cell types to transdifferen-
tiate from monocytic precursors. However, all of these
studies suffered from the lack of defined conditions (such
as by using serum, conditioned media or undefined lym-
phocyte-derived signals) and/or employed a monocyte
subfraction as the starter population. In contrast, we now
introduce a common pathway, and define the signals
required, for allowing monocytes to quantitatively con-
vert into a state of high developmental plasticity from
which FDC-like cells can be deduced. It needs to be
stressed that our results do not per se give a definitive clue
as to the normal pathway of FDC differentiation. In fact,
contemplating the actual existence of such a principal dif-
ferentiation path may either unravel the main pathway of
FDC generation or a salvage route, respectively. Normal
FDCs in situ express some myeloid markers such as CD14
and CD11b but not CD68. However, FDC tumors have
been described to also express CD68 [47-49]. In any case,
the myeloid pathway desribed here obviously comple-
ments our previous findings on the ontogeny of T cell-
directed DCs in that monocytes [20] and their myeloid
precursors [50] can both be induced to quantitatively
develop into T cell-tropic DCs, as is now commonly
acknowledged.
Interestingly, AP and CD35 expression as well as antigen
capture were occasionally observed to spontaneously
emerge in single cells within control macrophage cultures.
It thus becomes increasingly obvious that monocytes,
macrophages, T-cell tropic DCs and FDCs belong to a con-
Table 1: Phenotype and function of primary and secondary FDC-like cells as compared with macrophages generated in vitro and with 
freshly prepared monocytes
Monocytes [day 0] Macrophages [day 15] Primary FDC-like cells [day 15] Secondary FDC-like cells [day 18]
HLA-DR + ++ + ++
CD22 - - ± ±
CD35 (CR1) + + +++ +++
CD45 +++ +++ ± N.D.
CD54 (ICAM-1) + - - ++
CD68 ++ +++ +± +±
CD106 (VCAM-1) - - - +
AP - - +++ +++
Clustering. - - ++ +++
B cell Rosetting - - +++ +++
Emperipolesis - - ++ ++
Antigen Retention - - +++ +++
Markers and functions are expressed as absent (-), faintly or few positive cells (+), positive with different intensities (+, ++, +++), variable with 
respect to donor variations (±). The term, clustering, refers to the ability to establish homotypic and heterotypic aggregates. N.D. not determined.BMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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tinuum of a developmentally plastic system of cells which
are highly interconvertible. Further data expand this view
to osteoblasts, which were recently differentiated from a
monocyte subset [24], thus supporting our results on
overlapping phenotypes between osteoclasts, osteoblasts,
dendritic cells and macrophages [27].
Moreover, as mentioned before, even cell classes generally
considered to be developmentally distant from the mye-
loid lineage can be readily obtained from monocytes
when the appropriate signals are provided. Hence, when
acknowledging the monocyte as a previously ignored spe-
cies of somatic stem cell, it appears unlikely that this fas-
cinating cell type has already disclosed its entire potential.
It will indeed be exciting to witness which ontogenetic
surprises and therapeutic promises the future may hold.
Conclusion
Here we provide evidence that monocytes can be transdif-
ferentiated in vitro into cells that resemble FDCs by several
markers and functions. Immunocytochemical co-stain-
ings suggest thatthese cells had a myeloid origin. An
attractive feature of our findings isthat theyprecisely
describe stimuli enabling a transdifferentiation of mono-
cytes into FDC-like cells at defined serum-free conditions.
As a result, FDC-like cells can now be quantitatively pro-
duced in vitro for the first time, thereby offering a broad
application spectrum ranging from basic research to clin-
ical employment.
Methods
Monocyte isolation and culture
Leukocytes were obtained from leukapheresis of healthy
blood donors, in addition with serum supplied by the
blood transfusion service, University Hospital, Goettin-
gen. Mononuclear cells were prepared by standard Ficoll-
Hypaque (Nycomed, Oslo, Norway) gradient sedimenta-
tion, diluted with PBS to a final density of 1.068, resulting
in an enrichment of monocytes of about 70%, and
washed free of platelets. In some experiments, monocytes
were obtained from counterflow elutriation (Elutra, Gam-
bro, Martinsried, Germany). Cells were seeded into micro-
wells at 30.000 monocytes/well, in the presence of 10% of
0.45 µm filtered human pooled serum and allowed to
attach for a one hour. In order to obtain highly purified
monocytes non-attached cells were separated from mono-
cytes by a hanging-drop technique here referred to as
reverse sedimentation: Flat-bottom wells were filled up
with culture medium to form a convex meniscus, the
microplates were then gently turned upside-down and
cultured for 2 h in the inverted position. The medium
containing non-attached cells was snicked off, and the
adherent cells of about 95% purity (FACS analysis of
CD14 positive cells, not demonstrated) were further cul-
tured in 100 µl of differentiation medium: CellGro serum
free medium (CellGenix, Freiburg, Germany) supple-
mented with N-acetyl-L-alanyl-L-glutamine (Biochrom,
Berlin, Germany), penicillin/streptomycin (Biochrom),
10-6  M dexamethasone dinatrium phosphate (Ratiop-
harm, Ulm, Germany), 25 U/ml recombinant human Il-4,
3 U/ml recombinant human GM-CSF (R&D Systems,
Wiesbaden, Germany). Lymphocytes, if still present, were
additionally washed away on the second day. Once a
week, medium plus additives were completely exchanged.
During the entire cell preparation and culture care was
taken to minimize evaporation and pH shift to alkaline.
At day 15 the cultures were terminated or, alternatively,
additional inducers (recombinant TNF-α, LT-α/β, IFN-γ
(R&D Systems)) were added at day 13 for another three
days. For control, macrophages were differentiated in
medium consisting of each 50% "Medium 199" and RPMI
(Biochrom) supplemented with penicillin/streptomycin
and 10% heat-inactivated human serum (pooled from 30
healthy donors).
Immunocytochemistry
For staining procedures cells were fixed in ethanol/acetic
acid (95%/5%) for 30 min or alternatively with cold
methanol for 5 min and rehydrated by 3× washing in dis-
tilled water. Antibodies (from Dako, Glowstrup, Den-
mark, if not stated otherwise) were diluted in medium
plus 10% human sera: anti-CD68 clone EMB11 1:100,
anti-human CD35 (FDC) 1:30, anti-human CD54 1:800,
anti-human CD106 1:30, anti-human HLA-DR 1:200,
anti-human CD45 1:100, anti-human CD22 1:50, AP-
anti-human IgM 1:50, goat-AP-anti-mouse IgG 1:30, anti-
BrdU, (Amersham, Braunschweig, Germany) undiluted,
sheep-PO-anti mouse IgG, (Amersham) 1:300. The pri-
mary antibodies were incubated over night at 4°C, the
secondary antibodies at RT for 45 min. After each incuba-
tion step the preparations were washed with PBS. The PO-
staining was developed with H2O2 (1 µl/5 ml) and diami-
nobenzidine (50 µg/ml) in PBS/distilled water 1:1. The
AP-conjugated secondary antibodies were detected with
Naphthol/Fast Red, Sigma Deisenhofen, Germany,
including levamisole to inhibit edogenous AP activity.
Staining controls were done by omitting the primary
antibodies. The substrate reactions were observed
microscopically and stopped with PBS. The preparations
were stored in PBS/glycerine 1:1 at 20°C. For immuno-
doublestaining the preparation after the first staining pro-
cedure was washed extensively with PBS, the next
immunostaining was performed using a differently conju-
gated secondary antibody.
Enzyme cytochemistry for AP
The enzymecytochemical detection of AP was performed
using a test kit from Sigma according to the manufactures
instructions with the following modification: The culturesBMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
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were fixed as described for immunocytochemistry. The
enzyme reaction was carried out at RT for 20 min.
Enzyme cytochemical/immunocytochemical double or 
triple staining
Enzymecytochemical staining was performed prior to
immunostaining. After enzymestaining the preparation
was washed 3× in distilled water, the subsequent immu-
nostaining was performed as described above. For further
immunostaining the preparation was washed again exten-
sively before the next immunostaining was performed
using a differently conjugated secondary antibody.
Cell proliferation assay
Cell proliferation was determined by incorporation of
BrdU for 24 h into the nuclei follwed by immunostaining
with PO using a test kit from Amersham according to the
manufacturer's instructions.
Immunoglobulin aggregation
In order obtain aggregated immunoglobulines a purified
immunoglobulin preparation (Polyglobin, Behringwerke,
10% Ig in physiologic saline) was used at 10% in PBS and
incubated for 60 min at 60°C.
B-cell rosetting and emperipolesis
Raji cells (human B cell line) were used as a source of B
lymphocytes. For demonstrating rosetting or
emperipolesis, the Raji cells were cocultured at 3 × 104
cells/microwell with the monocyte-derived cells. After 4
hours the cultures were fixed with ethanol/acetic acid
stained, as above and evaluated microscopically.
Antigen trapping
Horseradish peroxidase (Calbiochem, Bad Soden/Ts, Ger-
many) was employed as a model antigen. The enzyme was
offered in the form of immune complexes of human Ig
(Behringwerke Marburg, Germany), HRPO-anti-human
IgG (goat) plus HRPO-anti-goat IgG for enhancing the
reaction. Immune complexes were added at 10% on day
12 to 15 for 30 min, thereafter the medium was changed.
After further incubation up to 16 days the cultures were
fixed with methanol for 5 min. and stained for peroxidase
as described for immunocytochemistry and reacted for
about 10–15 min. The reaction was stopped by washing
with distilled water.
Authors' contributions
DH has proposed the APpos phenotype to be the link to
FDCs. She has established the main protocol for genera-
tion of APpos cells from monocytes as well as most of the
experiments. JHP has developed the novel described
monocyte purification, introduced the use of Il-13 as
equivalent to Il-4. He contributed to the theoretical
framework.
Acknowledgements
This work was generously supported by a grant of the Gesellschaft für Biol-
ogische Krebsabwehr. The DC Society for Dendritic Cell Therapy, Goet-
tingen, kindly supplied support. We are indebted to Anja Bornholdt, 
Dorothea Ostermeier, Christina Schipper and Andrea Struck for technical 
help. We cordially thank Robert Gieseler (LTBH Medical Research Insti-
tute) for critically reading the manuscript.
References
1. Heinen E, Bosseloir A, Bouzahzah F: Follicular dendritic cells: ori-
gin and function.  Curr Top Microbiol Immunol 1995, 201:15-47.
2. van Nierop K, de Groot C: Human follicular dendritic cells:
function, origin and development.  Semin Immunol 2002,
14:251-257.
3. Imazeki N, Senoo A, Fuse Y: Is the follicular dendritic cell a pri-
marily stationary cell?  Immunology 1992, 76:508-510.
4. Yoshida K, van den Berg TK, Dijkstra CD: The functional state of
follicular dendritic cells in severe combined immunodefi-
cient (SCID) mice: role of the lymphocytes.  Eur J Immunol
1994, 24:464-468.
5. Yoshida K, Kaji M, Takahashi T, van den Berg TK, Dijkstra CD: Host
origin of follicular dendritic cells induced in the spleen of
SCID mice after transfer of allogeneic lymphocytes.  Immunol-
ogy 1995, 84:117-126.
6. Kapasi ZF, Qin D, Kerr WG, Kosco-Vilbois MH, Shultz LD, Tew JG,
Szakal AK: Follicular dendritic cell (FDC) precursors in pri-
mary lymphoid tissues.  J Immunol 1998, 160:1078-1084.
7. Yamakawa M, Imai Y, Dobashi M, Kasajima T: Development of fol-
licular dendritic cells: a study using short-term bone marrow
cell grafting in SCID mice.  Histol Histopathol 1999, 14:135-142.
8. Schriever F, Freeman G, Nadler LM: Follicular dendritic cells con-
tain a unique gene repertoire demonstrated by single-cell
polymerase chain reaction.  Blood 1991, 77:787-791.
9. Humphrey JH, Grennan D, Sundaram V: The origin of follicular
dendritic cells in the mouse and the mechanism of trapping
of immune complexes on them.  Eur J Immunol 1984, 14:859-864.
10. Fliedner A, Parwaresch MR, Feller AC: Induction of antigen
expression of follicular dendritic cells in a monoblastic cell
line. A contribution to its cellular origin.  J Pathol 1990,
161:71-77.
11. Krenacs T, Rosendaal M: Immunohistological detection of gap
junctions in human lymphoid tissue: connexin43 in follicular
dendritic and lymphoendothelial cells.  J Histochem Cytochem
1995, 43:1125-1137.
12. Parwaresch MR, Radzun HJ, Feller AC, Peters KP, Hansmann ML:
Peroxidase-positive mononuclear leukocytes as possible pre-
cursors of human dendritic reticulum cells.  J Immunol 1983,
131:2719-2725.
13. Bosseloir A, Heinen E, Defrance T, Bouzhazha F, Antoine N, Simar LJ:
Moabs MAS516 and 5B5, two fibroblast markers, recognize
human follicular dendritic cells.  Immunol Lett 1994, 42:49-54.
14. Muretto P: Immunohistochemical study of tonsils from new-
born infants with emphasis on follicular dendritic reticulum
cells.  Eur J Histochem 1998, 42:189-195.
15. Liu YJ, Grouard G, de Bouteiller O, Banchereau J: Follicular den-
dritic cells and germinal centers.  Int Rev Cytol 1996,
166:139-179.
16. Lee IY, Choe J: Human follicular dendritic cells and fibroblasts
share the 3C8 antigen.  Biochem Biophys Res Commun 2003,
304:701-707.
17. Muller-Hermelink HK, von Gaudecker B, Drenckhahn D, Jaworsky K,
Feldmann C: Fibroblastic and dendritic reticulum cells of lym-
phoid tissue. Ultrastructural, histochemical, and 3H-thymi-
dine labeling studies.  J Cancer Res Clin Oncol 1981, 101:149-164.
18. Imal Y, Yamakawa M: Morphology, function and pathology of
follicular dendritic cells.  Pathol Int 1996, 46:807-833.
19. Takahashi K: [Development and differentiation of macro-
phages and their related cells].  Hum Cell 1994, 7:109-115.
20. Peters JH, Ruhl S, Friedrichs D: Veiled accessory cells deduced
from monocytes.  Immunobiology 1987, 176:154-166.
21. Peters JH, Gieseler R, Thiele B, Steinbach F: Dendritic cells: from
ontogenetic orphans to myelomonocytic descendants.  Immu-
nol Today 1996, 17:273-278.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Immunology 2005, 6:23 http://www.biomedcentral.com/1471-2172/6/23
Page 13 of 13
(page number not for citation purposes)
22. Sievers J, Parwaresch R, Wottge HU: Blood monocytes and
spleen macrophages differentiate into microglia-like cells on
monolayers of astrocytes: morphology.  Glia 1994, 12:245-258.
23. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T,
Koga T, Martin TJ, Suda T: Origin of osteoclasts: mature mono-
cytes and macrophages are capable of differentiating into
osteoclasts under a suitable microenvironment prepared by
bone marrow-derived stromal cells.  Proc Natl Acad Sci U S A
1990, 87:7260-7264.
24. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y,
Kawakami Y, Ikeda Y: Human circulating CD14+ monocytes as
a source of progenitors that exhibit mesenchymal cell
differentiation.  J Leukoc Biol 2003, 74:833-845.
2 5 . Z h a o  Y ,  G l e s n e  D ,  H u b e r m a n  E :  A human peripheral blood
monocyte-derived subset acts as pluripotent stem cells.  Proc
Natl Acad Sci U S A 2003, 100:2426-2431.
26. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner
N, Zuzarte ML, Adamkiewicz J, Elsasser HP, Muller R, Havemann K:
Endothelial-like cells derived from human CD14 positive
monocytes.  Differentiation 2000, 65:287-300.
27. Heinemann DE, Siggelkow H, Ponce LM, Viereck V, Wiese KG, Peters
JH: Alkaline phosphatase expression during monocyte differ-
entiation. Overlapping markers as a link between monocytic
cells, dendritic cells, osteoclasts and osteoblasts.  Immunobiol-
ogy 2000, 202:68-81.
28. Heinemann DE, Lohmann C, Siggelkow H, Alves F, Engel I, Koster G:
Human osteoblast-like cells phagocytose metal particles and
express the macrophage marker CD68 in vitro.  J Bone Joint
Surg Br 2000, 82:283-289.
29. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME: Evidence
for an inverse relationship between the differentiation of adi-
pocytic and osteogenic cells in rat marrow stromal cell
cultures.  J Cell Sci 1992, 102 ( Pt 2):341-351.
30. Rademakers LH, De Weger RA, Roholl PJ: Identification of alka-
line phosphatase positive cells in human germinal centres as
follicular dendritic cells.  Adv Exp Med Biol 1988, 237:165-169.
31. Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera
RD, Delsol G, De Wolf-Peeters C, Falini B, Gascoyne RD, Gaulard P,
Gatter KC, Isaacson PG, Jaffe ES, Kluin P, Knowles DM, Mason DY,
Mori S, Muller-Hermelink HK, Piris MA, Ralfkiaer E, Stein H, Su IJ,
Warnke RA, Weiss LM: Tumours of histiocytes and accessory
dendritic cells: an immunohistochemical approach to classi-
fication from the International Lymphoma Study Group
based on 61 cases.  Histopathology 2002, 41:1-29.
32. Maeda K, Matsuda M, Suzuki H, Saitoh HA: Immunohistochemical
recognition of human follicular dendritic cells (FDCs) in rou-
tinely processed paraffin sections.  J Histochem Cytochem 2002,
50:1475-1486.
33. Tsunoda R, Nakayama M, Heinen E, Miyake K, Suzuki K, Sugai N,
Kojima M: Emperipolesis of lymphoid cells by human follicular
dendritic cells in vitro.  Virchows Arch B Cell Pathol Incl Mol Pathol
1992, 62:69-78.
34. Tew JG, Mandel TE, Phipps RP, Szakal AK: Tissue localization and
retention of antigen in relation to the immune response.  Am
J Anat 1984, 170:407-420.
35. Tsunoda R, Nakayama M, Onozaki K, Heinen E, Cormann N, Kinet-
Denoel C, Kojima M: Isolation and long-term cultivation of
human tonsil follicular dendritic cells.  Virchows Arch B Cell Pathol
Incl Mol Pathol 1990, 59:95-105.
36. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ,
Chaplin DD: Role of lymphotoxin and the type I TNF receptor
in the formation of germinal centers.  Science 1996,
271:1289-1291.
37. Wang Y, Wang J, Sun Y, Wu Q, Fu YX: Complementary effects of
TNF and lymphotoxin on the formation of germinal center
and follicular dendritic cells.  J Immunol 2001, 166:330-337.
38. Kim HS, Zhang X, Choi YS: Activation and proliferation of follic-
ular dendritic cell-like cells by activated T lymphocytes.  J
Immunol 1994, 153:2951-2961.
39. Parmentier HK, van der Linden JA, Krijnen J, van Wichen DF, Rade-
makers LH, Bloem AC, Schuurman HJ: Human follicular dendritic
cells: isolation and characteristics in situ and in suspension.
Scand J Immunol 1991, 33:441-452.
40. Schriever F, Nadler LM: The central role of follicular dendritic
cells in lymphoid tissues.  Adv Immunol 1992, 51:243-284.
41. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP: Osteogenic dif-
ferentiation of purified, culture-expanded human mesenchy-
mal stem cells in vitro.  J Cell Biochem 1997, 64:295-312.
42. Matasic R, Dietz AB, Vuk-Pavlovic S: Dexamethasone inhibits
dendritic cell maturation by redirecting differentiation of a
subset of cells.  J Leukoc Biol 1999, 66:909-914.
43. Ujihara M, Nomura K, Yamada O, Shibata N, Kobayashi M, Takano K:
Granulocyte-macrophage colony-stimulating factor ensures
macrophage survival and generation of the superoxide
anion: a study using a monocytic-differentiated HL60
subline.  Free Radic Biol Med 2001, 31:1396-1404.
44. Spiegel H, Herbst H, Niedobitek G, Foss HD, Stein H: Follicular
dendritic cells are a major reservoir for human immunodefi-
ciency virus type 1 in lymphoid tissues facilitating infection of
CD4+ T-helper cells.  Am J Pathol 1992, 140:15-22.
45. Jeffrey M, McGovern G, Goodsir CM, Brown KL, Bruce ME: Sites of
prion protein accumulation in scrapie-infected mouse spleen
revealed by immuno-electron microscopy.  J Pathol 2000,
191:323-332.
46. Smith BA, Gartner S, Liu Y, Perelson AS, Stilianakis NI, Keele BF,
Kerkering TM, Ferreira-Gonzalez A, Szakal AK, Tew JG, Burton GF:
Persistence of infectious HIV on follicular dendritic cells.  J
Immunol 2001, 166:690-696.
47. Masunaga A, Nakamura H, Katata T, Furubayashi T, Kanayama Y,
Yamada A, Shiroko Y, Itoyama S: Follicular dendritic cell tumor
with histiocytic characteristics and fibroblastic antigen.
Pathol Int 1997, 47:707-712.
4 8 . R i e d e l  F ,  B a c k  W ,  G o t t e  K ,  H o r m a n n  K :  [Follicular dendritic
reticulum cell sarcoma in a cervical lymph node].  Hno 2001,
49:837-841.
49. Andriko JW, Kaldjian EP, Tsokos M, Abbondanzo SL, Jaffe ES: Retic-
ulum cell neoplasms of lymph nodes: a clinicopathologic
study of 11 cases with recognition of a new subtype derived
from fibroblastic reticular cells.  Am J Surg Pathol 1998,
22:1048-1058.
50. Gieseler RK, Rober RA, Kuhn R, Weber K, Osborn M, Peters JH:
Dendritic accessory cells derived from rat bone marrow pre-
cursors under chemically defined conditions in vitro belong
to the myeloid lineage.  Eur J Cell Biol 1991, 54:171-181.